Authors

Bingyin Wang

Type

Text

Type

Dissertation

Advisor

Wimmer, Eckard | Hearing, Patrick | Krug, Laurie | Carter, Carol.

Date

2015-12-01

Keywords

codon pair bias, vaccine development, Vesicular stomatitis virus | Virology

Department

Department of Molecular Genetics and Microbiology.

Language

en_US

Source

This work is sponsored by the Stony Brook University Graduate School in compliance with the requirements for completion of degree.

Identifier

http://hdl.handle.net/11401/76546

Publisher

The Graduate School, Stony Brook University: Stony Brook, NY.

Format

application/pdf

Abstract

Codon pair bias (CPB), which has been observed in all organisms, is a neglected genomic phenomenon that substantially affects gene expression. CPB results from synonymous codons that are paired more or less frequently in ORFeomes regardless of codon bias. The effect of an individual codon pair change is usually small, but when amplified by large-scale genome recoding (simultaneously generating hundreds of synonymous mutations without altering codon usage or amino acid sequence), strikingly altered biological phenotypes are observed. Although the molecular mechanism underlying codon pair bias still remains enigmatic, the utility of codon pair bias in the development of live attenuated vaccines was recently demonstrated by recodings of poliovirus (a positive-strand RNA virus) and influenza virus (a negative-strand segmented RNA virus). In an attempt to expand the attenuation spectrum of codon pair bias, I recoded the L and G genes of vesicular stomatitis virus (VSV), a non-segmented negative strand RNA virus. For L gene recoding, I introduced a total of 858 and 623 silent mutations into a 5’-terminal segment of the viral L gene (designated as L1), to create sequences containing either overrepresented (sdmax design) and underrepresented (min design) codon pairs, respectively. These two sequences were designated as L1sdmax and L1min, respectively. Recombinant VSV containing the L1min sequence could not be recovered via a well-established reverse genetics system whereas the introduction of the L1sdmax sequence into the viral genome conferred a modest level of attenuation in cell culture. The phenotype of the L1sdmax virus was unexpected, which might result from a discoordination between translation elongation rate and protein folding kinetics. More strikingly, in mice the L1sdmax virus was almost as immunogenic as the parental strain but highly attenuated. Despite this, the recombinant virus showed a temporarily productive replication in the infected tissues while neither histopathological change nor severe morbidity has ever been found in L1sdmax- infected animals. As for the G gene recoding, I introduced 323 silent mutations into the G gene open- reading frame. The newly generated recombinant virus was designated as Gmin, which contained hundreds of underrepresented codon pairs. Although during the early stages of virus infection significantly less G gene products were produced in infected cells, the Gmin virus replicated just as well as its parental strain in tissue culture and showed neurovirulence in a mouse model. Taken together, my research suggests that L1sdmax, but not L1min or Gmin, is a promising live attenuated vaccine candidate for VSV infection. In addition, these results demonstrate a novel approach to attain a balance between VSV virulence and immunogenicity, which could serve as a paradigm for the attenuation of other negative-strand, non-segmented RNA viruses (NNS viruses). | Codon pair bias (CPB), which has been observed in all organisms, is a neglected genomic phenomenon that substantially affects gene expression. CPB results from synonymous codons that are paired more or less frequently in ORFeomes regardless of codon bias. The effect of an individual codon pair change is usually small, but when amplified by large-scale genome recoding (simultaneously generating hundreds of synonymous mutations without altering codon usage or amino acid sequence), strikingly altered biological phenotypes are observed. Although the molecular mechanism underlying codon pair bias still remains enigmatic, the utility of codon pair bias in the development of live attenuated vaccines was recently demonstrated by recodings of poliovirus (a positive-strand RNA virus) and influenza virus (a negative-strand segmented RNA virus). In an attempt to expand the attenuation spectrum of codon pair bias, I recoded the L and G genes of vesicular stomatitis virus (VSV), a non-segmented negative strand RNA virus. For L gene recoding, I introduced a total of 858 and 623 silent mutations into a 5’-terminal segment of the viral L gene (designated as L1), to create sequences containing either overrepresented (sdmax design) and underrepresented (min design) codon pairs, respectively. These two sequences were designated as L1sdmax and L1min, respectively. Recombinant VSV containing the L1min sequence could not be recovered via a well-established reverse genetics system whereas the introduction of the L1sdmax sequence into the viral genome conferred a modest level of attenuation in cell culture. The phenotype of the L1sdmax virus was unexpected, which might result from a discoordination between translation elongation rate and protein folding kinetics. More strikingly, in mice the L1sdmax virus was almost as immunogenic as the parental strain but highly attenuated. Despite this, the recombinant virus showed a temporarily productive replication in the infected tissues while neither histopathological change nor severe morbidity has ever been found in L1sdmax- infected animals. As for the G gene recoding, I introduced 323 silent mutations into the G gene open- reading frame. The newly generated recombinant virus was designated as Gmin, which contained hundreds of underrepresented codon pairs. Although during the early stages of virus infection significantly less G gene products were produced in infected cells, the Gmin virus replicated just as well as its parental strain in tissue culture and showed neurovirulence in a mouse model. Taken together, my research suggests that L1sdmax, but not L1min or Gmin, is a promising live attenuated vaccine candidate for VSV infection. In addition, these results demonstrate a novel approach to attain a balance between VSV virulence and immunogenicity, which could serve as a paradigm for the attenuation of other negative-strand, non-segmented RNA viruses (NNS viruses). | 135 pages

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.